During the Covid-19 crisis, NHS Trusts around the UK have postponed the opening of any new clinical trials and suspended some open trials.
For the time being, the Cannabidiol trial at Alder Hey Hospital remains active with existing patients still required to attend study visits in person.
No new patients have been admitted during the course of this crisis but it is projected now that new patients will be screened in July/August 2020 for both Alder Hey and the trial site at King’s College Hospital.
A third U.K. clinical trial is now planned to start at King’s College Hospital and other trial sites around the country in July 2020.
We are continuing to monitor the ongoing situation carefully. As the situation evolves, we will try to provide you with as much information as we can. If you are taking part in a trial have any direct concerns about potential COVID-19 infection, please use the NHS 111 online COVID-19 service.